Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-03CORT144Lyon Joseph Douglas plan to sell securities of CORCEPT THERAPEUTICS INC under Form 144MEDIUM
Lyon Joseph Douglas filed Form 144 to notify SEC of plan to sell 1540 units of CORCEPT THERAPEUTICS INC securities around 2026-08-03, with aggregate market value of $175,806.00. The total outstanding units is 107350000.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology
2026-08-03CAI144GEORGE H POSTE plan to sell securities of CARIS LIFE SCIENCES, INC. under Form 144MEDIUM
GEORGE H POSTE filed Form 144 to notify SEC of plan to sell 20000 units of CARIS LIFE SCIENCES, INC. securities around 2026-08-03, with aggregate market value of $325,000.00. The total outstanding units is 282680695.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Mid CapBiotechnology
2026-08-03CTNM144Daniel Lorrain plan to sell securities of CONTINEUM THERAPEUTIC INC under Form 144MEDIUM
Daniel Lorrain filed Form 144 to notify SEC of plan to sell 9520 units of CONTINEUM THERAPEUTIC INC securities around 2026-08-03, with aggregate market value of $147,464.80. The total outstanding units is 32958632.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past ...
Small CapBiotechnology
2026-08-03CTNM144CARMINE STENGONE plan to sell securities of Contineum Therapeutics, Inc. under Form 144MEDIUM
CARMINE STENGONE filed Form 144 to notify SEC of plan to sell 2500 units of Contineum Therapeutics, Inc. securities around 2026-08-03, with aggregate market value of $38,725.00. The total outstanding units is 32958632.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in p...
Small CapBiotechnology